Skip to main content Skip to footer content Disable Carousel Autoplay
Companion
First Edition
Microbiology

CLSI FR02

Isavuconazole Breakpoints for Aspergillus fumigatus

This CLSI rationale document is based on the need for guidance on the interpretation of antifungal agents for invasive aspergillosis.

March 12, 2025

{{FormatPrice(currentPrice)}}

Free

{{FormatPrice(nonMemberPrice)}} List Price
This is your member pricing.
Notify Me About New Editions
Product Details
FR02Ed1E
978-1-68440-273-1
14
Authors
Nathan P. Wiederhold, PharmD
David Andes, MD
Andrew M. Borman, BSc, PhD
Philippe J. Dufresne, PhD, RMCCM
Shawn Lockhart, PhD, D(ABMM), F(AAM)
Gary Procop, MD, MS, MEd
Authors
Nathan P. Wiederhold, PharmD
David Andes, MD
Andrew M. Borman, BSc, PhD
Philippe J. Dufresne, PhD, RMCCM
Shawn Lockhart, PhD, D(ABMM), F(AAM)
Gary Procop, MD, MS, MEd